Evaluation of folliculogenesis in poor responds women after intrauterine injection of autologous platelet-rich plasma
- Conditions
- Patients with poor ovarian response.
- Registration Number
- IRCT20220510054808N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 32
previous IVF (In vitro fertilisation) that resulted in the recovery of less than three eggs or an abnormal ovarian reserve test involving less than five AFCs (Antral follicle count )
All women have a regular menstrual cycle.
the level of follicles or AMH (Antimullerian Hormone) should be less than 1.1 ng / ml.
those under 40 years of age.
Autoimmune disorders, sexually transmitted diseases, infectious diseases, infertility / tubal factor tube obstruction, chronic inflammatory diseases, endometriosis, chronic endometritis, and endocrine disorders such as thyroid dysfunction.
anemia, thrombophilic disorders, current cancer diagnosis, or medical history of cancer
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Platelet-enriched plasma cell count. Timepoint: After plasma preparation. Method of measurement: With cell counting machine.
- Secondary Outcome Measures
Name Time Method Expression of folliculogenesis genes. Timepoint: After collecting granulosa cells on the day of oocyte someone both the control group and the treated group. Method of measurement: Real time PCR.;Hormone secretion levels. Timepoint: At monthly intervals after the puncture and before the puncture. Method of measurement: Immunoassay.;Antral follicle count. Timepoint: At monthly intervals after the puncture and before the puncture. Method of measurement: sonography.;The quality of oocytes. Timepoint: after puncture. Method of measurement: with stereomicroscope.;Oocyte and embryo quality. Timepoint: after puncture. Method of measurement: With a stereomicroscope.;Spontaneous fertility. Timepoint: 14 days after embryo transfer. Method of measurement: Pregnancy test and sonography.